Current clinical protocols for fetal cell transplantation for Parkinson's disease (PD) have focused on restoring dopamine in the striatum. However, there are now a number of human transplant recipients who have had robust innervation of the striatum by dopaminergic grafts (documented by positron emission tomography or by autopsy), but only a partial improvement in parkinsonian motor signs. Thus, there is a need for improved transplant strategies. In animal models of PD, there is recent evidence that restoring dopamine in the substan tia nigra, instead of or in addition to the striatum, may be important to correct abnormal motor behavior. This pilot study examined the morphological features and behavioral effects of fetal dopaminergic neuronal allografts placed into the substantia nigra of three l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)treated hemiparkinsonian rhesus monkeys. We show that grafts can survive in host substantia nigra. Charac teristics of the graft-host interface were variable. In one animal, reinnervation of host substantia nigra was observed, and this animal showed behavioral improvement in a reach-and-retrieval task.
INTRODUCTION
Attempts to correct human parkinsonism by grafting of dopamine-secreting fetal substantia nigra, pars compacta (SNc) cells into the striatum have been made since the mid-1980s. Despite often robust dopaminergic reinnervation of the striatum, however, the amelioration of parkinsonian motor signs has been only partial (17, 18, 26, 33, 40, 47, 50) . Thus, restoration of striatal do paminergic innervation alone, by heterotopic grafting of SNc cells into the striatum, may not be sufficient for complete recovery from Parkinson's disease (PD).
In addition to the long-distance nigrostriatal pathway, there are other, short-distance dopaminergic circuits arising from the SNc, which innervate neighboring nu clei. The best studied of these local dopamine circuits is a dense innervation of the substantia nigra, pars reticu lata (SNr) by dendrites of neurons whose cell bodies are located in the SNc (10) . The SNr borders and interdigitates with the SNc, and is one of the two major motor output nuclei of the basal ganglia, along with the globus pallidus internus (GPi) (1) . The dopaminergic innerva tion of the SNr is likely to be severely depleted in PD, because it arises from the ventral tier of the SNc (10) , which is the region of the SNc that is most severely affected in idiopathic PD (20) .
In the 6-hydroxydopamine (6-OHDA) rodent model of PD, restoration of dopamine in the SNr can correct motor abnormalities in several types of experimental paradigms. Orthotopic transplantation of fetal dopamin ergic SNc cells into the lesioned SNc of adult rats, with out intrastriatal transplantation, both diminishes abnor mal drug-induced rotation and improves skilled motor function (25, 31, 32) . The intranigral grafts in these ex periments showed local reinnervation of the SNr, but did not send long-distance projections to the striatum. "Rescue" of lesioned SNc cells by treatment with glial cell line-derived neurotrophic factor (GDNF) corrects abnormal drug-induced rotation by a mechanism that does not involve striatal dopamine and may be mediated via the SNr (45) . Pharmacological data also suggest that dopaminergic transmission in the SNr may be involved in motor function in the rat, because injection of D! re ceptor agonists directly into the SNr in 6-OHDA-treated animals produces typical rotational behavior [reviewed in (37) ].
supports an important role for extrastriatal dopamine in parkinsonian pathophysiology. Intracerebral injection of GDNF in such monkeys results in sprouting of nigral dopaminergic fibers, restoration of nigral dopamine lev els, and substantial amelioration of motor abnormalities, but without restoration of dopaminergic innervation in the striatum (19) .
These studies in rodent and nonhuman primate mod els indicate that restoration of dopamine in the substan tia nigra, without restoration of striatal dopamine, may be beneficial in parkinsonism. Nevertheless, there are no published studies on intranigral transplantation of fetal allograft SNc in a primate. In this study, we evaluated the morphological features and behavioral effects of fe tal dopaminergic neuronal allografts placed into the sub stantia nigra (SN) of MPTP-treated rhesus monkeys.
MATERIALS AND METHODS

Three rhesus monkeys (Macaca mulatto)
(monkeys 1-3) weighing 4-5 kg were used for this study. All pro cedures were in strict compliance with the Principles of Laboratory Animal Care (NIH publication No. 86-23, rev. 1985) and were approved by the Emory University Institutional Animal Care and Use Committee.
Surgical Procedures
Animals were treated with 2-3 unilateral intracarotid injections with MPTP (0.4 mg/kg) 1 week apart (6) . This treatment led to initially severe hemiparkinsonian signs, most prominently bradykinesia, rigidity, and flexed pos ture contralateral to the injected side. The animals recov ered partially over the first few weeks, until they reached a moderately hemiparkinsonian state, which then remained stable. Weekly behavioral testing con firmed the stability of parkinsonian signs for 2 months (monkey 1) or 3 months (monkeys 2 and 3) following the final MPTP injection.
Under general anesthesia with isoflurane, recording chambers were stereotactically positioned over a tre phine hole in the skull, aimed at the SNr at an angle of 30° anterior to the vertical, and held in place with dental acrylic. Metal head holders were also embedded into the acrylic cap to permit head stabilization during the re cording procedures.
Microelectrode Mapping
A total of 20-40 microelectrode penetrations were 
Harvesting and Infusion of Fetal Neuronal Cells
Fetal harvest was performed by C-section, under gen eral anaesthesia, from pregnant female rhesus monkeys at 35^2 days gestational age. Crown-rump length was 18-19 mm in all cases. One fetus was used for each recipient. The ventral mesencephalon (VM) was dis sected from surrounding brain tissue and meninges by standard methods (14) and placed in a petri dish contain ing cold Hank's balanced salt solution (HBSS). The VM was cut in half along the midline, and each half was further cut into 4-5 approximately cubic pieces with a scalpel blade. Each half VM was loaded into a 22-gauge injection cannula, in 15-25 |il of HBSS, by gentle aspi ration with a 50-ul Hamilton syringe attached to the in jection cannula with a short segment of tubing. Each half VM was injected into the recipient SNr along one of two parallel injection tracks separated by 2 mm, at a rate of 1 ul/min. Target coordinates for the tissue injec tions were derived from the previously described micro electrode map, based on the physiologically determined borders of the SNr. Tissue was infused into transplant recipients within 2 h of harvest. Recipient animals were not immunosuppressed.
Behavioral Testing
The animals were trained to sit in a primate chair and to permit handling by the experimenter. For the first 3 months posttransplant, behavioral testing was performed 2-3 times/week. In the remaining posttransplant months testing was carried out 2-3 times every other week. Ani mals were food restricted (to 90-95% of their baseline weight) for at least 2 days prior to behavioral testing.
The following tasks were performed in the normal state, the hemiparkinsonian, pretransplant state, and repeatedly up to 4 months (monkey 1) or 6 months (monkeys 2 and 3) after transplantation:
1. Reaching and retrieval task. The animals were trained in a reaching and retrieval task to assess limb hypokinesia/bradykinesia. A modified Kliiver board with 16 wells, each containing a raisin, was presented to the monkey in a standard manner. The time re quired for the monkey to empty all wells (up to a maximum of 90 s) was measured, and the average time needed to retrieve one raisin was calculated.
Testing was done in duplicate on each experimental day for each side, while the contralateral arm was restrained at the monkey's side.
2. Infrared beam crossing. The spontaneous activity was measured by counting infrared beam crossings during a 60-min period. The observation cage was equipped with two sets of four infrared beams each. The first set was oriented between front and back of the cage with the beams arranged at the corners of a 15-in. square; the second set was attached similarly to the side walls of the cage. Each time the animal crossed an infrared beam, a TTL pulse was generated and registered by a computer. The number of cross ings of the lower infrared beams (counted by the computer) served as a measure of general cage motil ity, and thus, as a measure of generalized hypo kinesia. Simultaneous crossing of a lower and an up per beam indicated that the animal assumed an upright posture. Off-line analysis of the computer data yielded the percentage of time spent upright.
Behavioral data were pooled into the following groups: Normal, all testing in the normal state; MPTP, all testing in the pretranplant, post-MPTP state; Trans plant I-III, all testing for each 2-month block following cell transplantation.
Brain Sectioning and Staining
At 4 months (monkey 1) or 6 months (monkeys 2 and 3) following transplantation, animals were anesthe tized with ketamine, and killed with an overdose of IV pentobarbital, followed by cardiac perfusion with 4% paraformaldehyde. The brain was harvested, and the midbrain/diencephalic region was cut into 70-|a.m para sagittal sections on a microtome (American Optical, New York, NY). Every fourth section was stained with a mouse monoclonal antibody against tyrosine hydroxy lase (TH) (Chemicon International Inc., Temecula, CA, 1:1000) using a DAB technique (ABC Elite kit, Vector Labs, Burlingame, CA), or with cresyl violet to high light Nissl substance, and examined by light micros copy.
RESULTS
Histology Dopamine
Depletion.
Intracarotid MPTP treatment clearly resulted in a loss of striatal and nigral TH immu noreactivity (TH-ir) consistent with dopamine denerva tion, in comparison with the normal, non-MPTP-lesioned side (Fig. 1A, B ).
Graft Size and Localization.
Graft location was de termined by analysis of Nissl-stained sections, as in Fig  ure 1C . Sections were compared to corresponding re gions in a macaque brain atlas (51) . Grafts were roughly cylindrical, with the same orientation as the injection tracks. They measured approximately 2-3 mm in diame ter and 5-7 mm long. Exact graft location was different for each monkey. In monkey 1, there were two distinct grafts corresponding to the two injection tracks. The me dial graft was located in the dorsal SN region (Fig. 1C) . The superior portion bordered the STN. The lateral graft (not shown) occupied the lateral SN region, but ex tended inferior to the SN to impinge on the lateral part of the corticospinal tract. In monkey 2, graft tissue from the two injection tracks appeared to merge together on most sections. The superior portion of the graft ( Fig. 2A,  B) was located in the SN. The graft traversed the inferior margin of the SN and extended several millimeters into the pontine tegmentum, posterior to the corticospinal and corticobulbar tracts. In monkey 3, the graft tracks were clearly visible traversing the SN (Fig. 3 ), but the graft itself was located inferior to the SN in the pontine tegmentum.
Damage
to Motor Structures. The injection tracks passed very close to the STN in monkeys 1 and 3, and one track passed through the STN in monkey 2. How ever, there was no sign of gross damage to the STN in any monkey. Other than the lateral track in monkey 1, no track impinged on the corticospinal tract. There were no signs of resolving hematomas.
Graft Survival and Internal
Architecture.
In all cases, grafts showed densely staining TH-positive cells and fibers. Cellular architecture in many regions was disorderly with variations in cell density and spacing not seen in normal SN (Fig. ID) . There was no sign of ne crosis or lymphocytic infiltration.
Integration
Into Surrounding Tissue. Graft tissue lo cated in inferior SN in monkey 2 showed robust exten sion of fibers into surrounding tissues ( Fig. 2A-C) . In terestingly, the portion of the graft that was not within the SN had a clearly different morphology at the grafthost interface, with a much more "encapsulated" appear ance and lack of fiber extension outside of the graft ( Fig.   2A, B, D) . The graft located in dorsal SNr (monkey 1) did not show robust innervation of the host SNr nor of host STN (Fig. IB, D) , though its border was less de marcated than the extranigral region of the graft in mon key 2.
No Evidence of Injury-Induced Sprouting.
In several regions of monkeys 2 and 3, there were injection tracks seen traversing a part of the SN without deposit of graft tissue. In these regions, there was no sign of injury-in- 
Behavior Changes
All monkeys remained healthy and maintained a sta ble weight up until sacrifice. For both spontaneous activ ity ( Fig. 4) and performance in the reach-and-retrieval task ( Fig. 5 ), there was a clear, statistically significant effect of MPTP treatment (independent sample Mest).
Spontaneous activity showed a significant decrease with MPTP, with the number of infrared beam crossings de creasing by 40-80%. The required time for the monkey to retrieve individual raisins in the reach-and-retrieval task was prolonged by 200-300%, indicating significant limb bradykinesia. None of the monkeys developed tremor, and rigidity was mild.
Behavioral results of the grafting procedure varied for each monkey and are considered separately. Monkey 1. Immediately following the grafting proce dure, the spontaneous activity acutely improved (data not shown). This effect remained stable at 3^1 months postgrafting (Fig. 4A) . The limb movement time as tested in the food retrieval task showed a slight deterio ration (Fig. 5A) .
Monkey 2.
This monkey showed both acute and longer term changes. Acutely, spontaneous activity in creased, but this improvement declined at months 3-4
and further at months 4-5 (Fig. 4B ). Upright posture also improved acutely and stayed improved throughout (Fig. 5B) .
Monkey 3. This animal showed an acute significant worsening in both behavioral tests. Spontaneous activity showed an acute worsening, which remained stable for the 6-month evaluation period (Fig. 4C ). Although the performance in the food retrieval task did begin to re cover at months 4-6, it remained worse than in the pretransplant parkinsonian state (Fig. 5C ).
DISCUSSION
Fetal cell allografting for the correction of parkinson ism has previously been studied in the monkey (2, 3, 5, 7, 35, 39, 43) and in the human (17, 18, 26, 33, 40, 47, 50) . In all of these studies, SNc tissue was placed ectopically into the striatum, which is the predominant target of SNc projections. The striatum may contain a source of trophic support for developing SNc (34, 42, 44) .
Survival and integration of the allograft has been shown in the monkey up to 7-12 months (3, 39) and in the hu digms in the monkey, this should begin to occur at 1-2 months and peak at 4-6 months (2, 3, 5, 7, 35, 39, 43) .
The early behavioral improvements seen in monkeys 1 and 2, and the worsening seen in monkey 3, were likely related to a lesion effect because they occurred immediately. Monkey 3 showed no longer term im provements, and this was the one animal in which no graft tissue was present within or bordering the SN. Graft tissue was present in the pontine tegmentum, hav ing been placed too deeply. Monkey 1 had acute changes (mixed improvement and worsening), all of which showed a gradual return to values similar to those in the parkinsonian state. This monkey had graft tissue bordering dorsal SN, but without graft integration into the SN. Monkey 2, the only animal that showed a statis tically significant delayed improvement (in the food re trieval task) starting with months 3-4, is also the only animal in this series that showed significant graft inte gration into the SNr on histological exam. Thus, the cor relation of the behavioral and histological data is consis tent with the hypothesis that orthotopic SNC allografts can produce a delayed motor improvement, occurring with a time course expected for graft maturation, and that this effect may depend upon graft integration into host SNr. An alternative explanation is that there was a general wearing off of MPTP parkinsonism. This is un likely because other features of parkinsonism, such as impaired spontaneous activity, persisted in this animal. Interestingly, the type of improvement seen in this mon key (i.e., improvement of coordinated limb movement) is similar to the type of behavior that improved in sev eral previous studies of intranigral grafting in the parkin sonian rat (25, 32) .
What are the possible mechanisms underlying behav ioral improvement with dopaminergic reinnervation of the SNr region? The SNr is one of the two major output nuclei of the basal ganglia, along with the GPi, and pro jects to motor areas of the thalamus and brain stem. Both single-unit recording and lesioning studies indicate that it may play a key role in the control of axial and limb movements (13, 29, 38, 48, 49) . In the normal animal, the SNr receives a dopaminergic innervation (10) , and this innervation is depleted in parkinsonism (24) . Like stria tal dopamine, nigral dopamine is released in awake, freely moving rats in response to depolarization or to drugs that stimulate catecholamine release (36) . Dopa mine in the SNr probably acts by modulating the release of GABA from striatonigral terminals, which express D! receptors and which synapse on SNr cells (37, 41, 46) . Intranigral grafts of mesencephalic tissue are likely to affect motor function in parkinsonian animals through the same mechanism (37). This, in turn, may alter nigrothalamic or nigrobulbar motor pathways.
Theoretically, grafts could innervate the STN, be cause the inferior border of the STN is immediately ros tral to the SNc, and parts of the STN normally receive dopaminergic input from the SNc (16, 22, 27, 30) . Dopa mine is probably inhibitory to the STN (12, 15) . If graft placement into the SNr also resulted in restoration of the dopaminergic innervation of the STN, activity in this nucleus could be affected with resulting changes in the electrophysiology of basal ganglia output nuclei as well as in animal behavior. However, in these experiments, this mechanism is unlikely. Although one graft track did graze the STN in monkey 2, there was no evidence of graft deposition in that nucleus. 
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